Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency Virus.

导出 OA

翻译打印收藏纠错

作者： Sahar,Saeed ^[1] ; Erin,Strumpf ^[2] ; Erica E M,Moodie ^[1] ; Leo,Wong ^[3] ; Joseph,Cox ^[1] ; Sharon,Walmsley ^[2] ; Mark,Tyndall ^[1] ; Curtis,Cooper ^[2] ; Brian,Conway ^[4] ; Mark,Hull ^[5] ; Valerie,Martel-Laferriere ^[6] ; John,Gill ^[5] ; Alexander,Wong ^[7] ; Marie-Louise,Vachon ^[8] ; Marina B,Klein ^[5] ; Canadian Coinfection Cohort Study Investigators ^[9]

作者单位： Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada. ^[1] Research Institute of the McGill University Health Centre, Montreal, Canada. ^[2] Department of Economics, McGill University, Montreal, Canada. ^[3] University Health Network, University of Toronto, Toronto, Canada. ^[4] Canadian Institute for Health Research, Canadian Human Immunodeficiency Virus Trials Network,, Vancouver, Canada. ^[5] British Columbia Centre for Disease Control, University of British Columbia, Vancouver, Canada. ^[6] Ottawa Hospital Research Institute, Ottawa, Canada. ^[7] Vancouver Infectious Diseases Centre, Vancouver, Canada. ^[8] British Columbia Centre of Excellence, St. Paul's Hospital, Vancouver, Canada. ^[9] Departement de Microbiologie et Infectiologie, Centre Hospitalier de l'Université de Montréal, Montreal, Canada. ^[10] Southern Alberta Human Immunodeficiency Virus Clinic, Calgary, Canada. ^[11] Regina Qu'Appelle Health Region, Regina, Canada. ^[12] Division of Infectious Diseases, Laval University, Québec City, Canada. ^[13]

关键词 HIV–hepatitis C coinfection direct-acting antivirals people who inject drugs quasi-experimental methods unrestricted access